Bayesian logistic regression model with optional EXchangeability-NonEXchangeability parameter modelling for flexible borrowing from historical or concurrent data-sources. The safety model can guide dose-escalation decisions for adaptive oncology Phase I dose-escalation trials which involve an arbitrary number of drugs. Please refer to Neuenschwander et al. (2008) <doi:10.1002/sim.3230> and Neuenschwander et al. (2016) <doi:10.1080/19466315.2016.1174149> for details on the methodology.
Version: | 0.6-5 |
Depends: | R (≥ 3.4.0), Rcpp (≥ 0.12.0), methods |
Imports: | assertthat (≥ 0.2.1), checkmate, Formula, rstan (≥ 2.19.3), rstantools (≥ 2.0.0), bayesplot (≥ 1.4.0), ggplot2 (≥ 2.2.1), dplyr (≥ 0.8.0), tibble, tidyr (≥ 1.0.0), abind |
LinkingTo: | StanHeaders (≥ 2.19.2), rstan (≥ 2.19.3), BH (≥ 1.72.0), Rcpp (≥ 0.12.0), RcppEigen (≥ 0.3.3.3.0) |
Suggests: | rmarkdown, knitr, testthat (≥ 2.0.0), mvtnorm |
Published: | 2020-05-07 |
Author: | Novartis Pharma AG [cph], Sebastian Weber [aut, cre], Lukas A. Widmer [aut], Andrew Bean [aut], Trustees of Columbia University [cph] (R/stanmodels.R, configure, configure.win) |
Maintainer: | Sebastian Weber <sebastian.weber at novartis.com> |
License: | GPL (≥ 3) |
NeedsCompilation: | yes |
SystemRequirements: | GNU make, pandoc (>= 1.12.3), pandoc-citeproc |
Materials: | NEWS |
CRAN checks: | OncoBayes2 results |
Reference manual: | OncoBayes2.pdf |
Vignettes: |
Guiding Oncology Dose-Escalation Trials |
Package source: | OncoBayes2_0.6-5.tar.gz |
Windows binaries: | r-devel: OncoBayes2_0.6-5.zip, r-release: OncoBayes2_0.6-5.zip, r-oldrel: OncoBayes2_0.6-5.zip |
macOS binaries: | r-release: OncoBayes2_0.6-5.tgz, r-oldrel: OncoBayes2_0.6-5.tgz |
Old sources: | OncoBayes2 archive |
Please use the canonical form https://CRAN.R-project.org/package=OncoBayes2 to link to this page.